Ultraviolet-C Effectiveness in the Management of Pressure Ulcers in People With Spinal Cord Injury

NCT01500174 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2012-09-05

No results posted yet for this study

Summary

The objective of the study is to examine the effectiveness of Ultraviolet-C (UVC) for healing pressure ulcers in people with spinal cord injury. UVC is a form of radiation similar to sunlight but it is normally absorbed in the earth's atmosphere. Participants will be assigned by chance to receive placebo-UVC or real UVC treatment, in addition to receiving wound care according to best practice guidelines. The hypothesis is that UVC-treated wounds will heal at a faster rate than wounds receiving placebo treatment.

Given that pressure ulcers impact on an individual's quality of life, and generate high costs to the overall health care system, further work is needed to explore alternative means of pressure ulcer treatment.

Conditions

  • Pressure Ulcer

Interventions

DEVICE

ultraviolet therapy UV254

three times per week until wound closure or patient discharge from hospital

DEVICE

Placebo ultraviolet therapy UV254

Three times per week irradiation of wound base and periwound skin

Sponsors & Collaborators

  • Ontario Neurotrauma Foundation

    collaborator OTHER
  • Toronto Rehabilitation Institute

    lead OTHER

Principal Investigators

  • Ethne L Nussbaum, PhD · Toronto Rehabilitation Institute

  • Colleen F McGillivray, MD, FRCPC · Toronto Rehabilitation Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-05-31
Completion
2011-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500174 on ClinicalTrials.gov